Long GG - Search Results

1

Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose.

Vahle JL, Long GG, Sandusky G, Westmore M, Ma YL, Sato M. Vahle JL, et al. Among authors: long gg. Toxicol Pathol. 2004 Jul-Aug;32(4):426-38. doi: 10.1080/01926230490462138. Toxicol Pathol. 2004. PMID: 15204966

2

Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety.

Vahle JL, Sato M, Long GG, Young JK, Francis PC, Engelhardt JA, Westmore MS, Linda Y, Nold JB. Vahle JL, et al. Among authors: long gg. Toxicol Pathol. 2002 May-Jun;30(3):312-21. doi: 10.1080/01926230252929882. Toxicol Pathol. 2002. PMID: 12051548

3

Variations in animal populations over time and differences in diagnostic thresholds used can impact tumor incidence data.

Vahle JL, Sato M, Long GG. Vahle JL, et al. Among authors: long gg. Toxicol Pathol. 2007 Dec;35(7):1045-6. doi: 10.1080/01926230701748354. Toxicol Pathol. 2007. PMID: 18098050 No abstract available.

4

Chronic Toxicity and Carcinogenicity Studies of the Long-Acting GLP-1 Receptor Agonist Dulaglutide in Rodents.

Byrd RA, Sorden SD, Ryan T, Pienkowski T, LaRock R, Quander R, Wijsman JA, Smith HW, Blackbourne JL, Rosol TJ, Long GG, Martin JA, Vahle JL. Byrd RA, et al. Among authors: long gg. Endocrinology. 2015 Jul;156(7):2417-28. doi: 10.1210/en.2014-1722. Epub 2015 Apr 10. Endocrinology. 2015. PMID: 25860029

5

Urothelial carcinogenesis in the urinary bladder of rats treated with naveglitazar, a gamma-dominant PPAR alpha/gamma agonist: lack of evidence for urolithiasis as an inciting event.

Long GG, Reynolds VL, Lopez-Martinez A, Ryan TE, White SL, Eldridge SR. Long GG, et al. Toxicol Pathol. 2008 Feb;36(2):218-31. doi: 10.1177/0192623307311757. Toxicol Pathol. 2008. PMID: 18474944

6

Neoplastic and non-neoplastic changes in F-344 rats treated with Naveglitazar, a gamma-dominant PPAR alpha/gamma agonist.

Long GG, Reynolds VL, Dochterman LW, Ryan TE. Long GG, et al. Toxicol Pathol. 2009 Oct;37(6):741-53. doi: 10.1177/0192623309343775. Epub 2009 Aug 21. Toxicol Pathol. 2009. PMID: 19700659

7

Proliferative lesions of ovarian granulosa cells and reversible hormonal changes induced in rats by a selective estrogen receptor modulator.

Long GG, Cohen IR, Gries CL, Young JK, Francis PC, Capen CC. Long GG, et al. Toxicol Pathol. 2001 Jul-Aug;29(4):403-10. doi: 10.1080/01926230152500004. Toxicol Pathol. 2001. Corrected and republished in: Toxicol Pathol. 2001 Nov-Dec;29(6):719-26. doi: 10.1080/019262301753386031 PMID: 11560244 Corrected and republished.

8

Proliferative lesions of ovarian granulosa cells and reversible hormonal changes induced in rats by a selective estrogen receptor modulator.

Long GG, Cohen IR, Gries CL, Young JK, Francis PC, Capen CC. Long GG, et al. Toxicol Pathol. 2001 Nov-Dec;29(6):719-26. doi: 10.1080/019262301753386031. Toxicol Pathol. 2001. PMID: 11794385

9

Appropriate parameters to be tested in rodent oncogenicity studies.

Long GG, Symanowski JT. Long GG, et al. Toxicol Pathol. 1998 May-Jun;26(3):319-20. doi: 10.1177/019262339802600305. Toxicol Pathol. 1998. PMID: 9608637 No abstract available.

10

Commentary on "Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary".

Long GG. Long GG. Toxicol Pathol. 2010 Apr;38(3):502-5. doi: 10.1177/0192623309359795. Epub 2010 Feb 2. Toxicol Pathol. 2010. PMID: 20124495 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters